Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach
- PMID: 17136864
Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach
Abstract
The cancer anorexia/weight loss syndrome occurs in over 80% of patients with incurable cancer and is associated with a poor prognosis and negative effects on quality of life. Educating patients and families plays an important role in its management, and caregivers sometimes forget that in select patients who are candidates for it, antineoplastic therapy can occasionally reverse some aspects of this syndrome. Patients may also benefit from appetite stimulants such as corticosteroids and progestational agents,and this review summarizes the benefits of using these agents as well as their contraindications.
Comment in
-
Treating the anorexia/cachexia syndrome.J Support Oncol. 2006 Nov-Dec;4(10):506-7. J Support Oncol. 2006. PMID: 17136865 No abstract available.
-
More research needed on the treatment of the cancer anorexia/cachexia syndrome.J Support Oncol. 2006 Nov-Dec;4(10):508-9. J Support Oncol. 2006. PMID: 17136866 No abstract available.